Matthew J deGraffenried

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Obesity is the leading preventable comorbidity associated with increased prostate cancer-related recurrence and mortality. Epidemiological and clinical studies indicate that a body mass index >30 is associated with increased oxidative DNA damage within the prostate gland and increased prostate cancer-related mortality. Here we provide evidence that obesity(More)
  • 1